ERT SEC-Einreichungen - Eresearchtechnology Inc- Jahresbericht, Proxy Statement, Prospekt

Basisstatistiken

CIK

1026650

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Eresearchtechnology Inc

SEC Filings (Chronological Order)

Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.

February 11, 2013	SC 13G/A	ERT / Eresearchtechnology Inc / VANGUARD GROUP INC Passive Investment SC 13G/A 1 eresearchtechnologyinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: eResearch Technology Inc Title of Class of Securities: COMMON STOCK CUSIP Number: 29481V108 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to designate the rule
January 31, 2013	SC 13G	ERT / Eresearchtechnology Inc / TOCQUEVILLE ASSET MANAGEMENT L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* eResearch Technology, Inc. (Name of Issuer) Common Stocks (Title of Class of Securities) 29481V108 (CUSIP Number) Calendar Year 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p
August 8, 2012	SC 13G/A	ERT / Eresearchtechnology Inc / COLUMBIA WANGER ASSET MANAGEMENT LLC - SC 13G/A Passive Investment SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) July 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedul
July 13, 2012	15-12G	- FORM 15 FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 0-29100 eResearchTechnology, Inc. (Exact name of registrant as speci
July 9, 2012	EX-3.1	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION ERESEARCHTECHNOLOGY, INC. ARTICLE I EX-3.1 3 d376369dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ERESEARCHTECHNOLOGY, INC. ARTICLE I The name of the corporation (the “Corporation”) is “eResearchTechnology, Inc.” ARTICLE II The address of the Corporation’s registered office in the State of Delaware is 1209 Orange Street in the City of Wilmington, County of New Castle, 19801. The name of its regist
July 9, 2012	8-K	Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2012 eResearchTechnology, Inc. (Exact name of Registrant as specified in Charter) Delaware 0-29100 22-3264604 (State or Other Jurisdiction of Incorporation) (Commissi
July 9, 2012	EX-3.2	AMENDED AND RESTATED BYLAWS ERESEARCHTECHNOLOGY, INC. (a Delaware corporation) Adopted as of July 3, 2012 TABLE OF CONTENTS Page ARTICLE I. IDENTIFICATION; OFFICES 1 Section 1. NAME 1 Section 2. PRINCIPAL AND BUSINESS OFFICES 1 Section 3. REGISTERED EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ERESEARCHTECHNOLOGY, INC. (a Delaware corporation) Adopted as of July 3, 2012 TABLE OF CONTENTS Page ARTICLE I. IDENTIFICATION; OFFICES 1 Section 1. NAME 1 Section 2. PRINCIPAL AND BUSINESS OFFICES 1 Section 3. REGISTERED AGENT AND OFFICE 1 Section 4. PLACE OF KEEPING CORPORATE RECORDS 1 ARTICLE II. STOCKHOLDERS 1 Section 1. ANNUAL MEETING 1 Sectio
July 9, 2012	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Completion of Acquisition or Disposition of Assets, Other Events - 8-K 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2012 eResearchTechnology, Inc. (Exact name of Registrant as specified in Charter) Delaware 0-29100 22-3264604 (State or Other Jurisdiction of Incorporation) (Commission Fi
July 9, 2012	EX-99.2	ERT Acquires invivodata to Establish the Industry’s Most Experienced Provider of Clinical Outcome Assessment Solutions EX-99.2 Exhibit 99.2 ERT Acquires invivodata to Establish the Industry’s Most Experienced Provider of Clinical Outcome Assessment Solutions PHILADELPHIA, PA, July 9 2012 /PRNewswire/ - ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and Contract Research Organizations (CROs), announced today the acquisition of invivodata, Inc, a leading provider o
July 9, 2012	EX-2.2	AGREEMENT AND PLAN OF MERGER BY AND AMONG EXPLORER HOLDINGS, INC. EXPLORER ACQUISITION CORP., IMPACT ACQUISITION CORP., INVIVODATA, INC., FORTIS ADVISORS LLC, AS THE STOCKHOLDER REPRESENTATIVE, June 29, 2012 TABLE OF CONTENTS PAGE Article 1. Definiti EX-2.2 Exhibit 2.2 AGREEMENT AND PLAN OF MERGER BY AND AMONG EXPLORER HOLDINGS, INC. EXPLORER ACQUISITION CORP., IMPACT ACQUISITION CORP., INVIVODATA, INC., AND FORTIS ADVISORS LLC, AS THE STOCKHOLDER REPRESENTATIVE, June 29, 2012 TABLE OF CONTENTS PAGE Article 1. Definitions 2 Section 1.01 Definitions 2 Section 1.02 Definitional and Interpretative Provisions 12 Article 2. The Merger 13 Section 2.
July 9, 2012	EX-99.1	Genstar Capital Completes ERT Acquisition In A Take-Private Transaction EX-99.1 Exhibit 99.1 Genstar Capital Completes ERT Acquisition In A Take-Private Transaction PHILADELPHIA, July 3, 2012/PRNewswire/—ERT (Nasdaq: ERT), a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private trans
July 3, 2012	S-8 POS	- S-8 POS S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization)
July 3, 2012	POS AM	- POS AM UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) (Address
July 3, 2012	POS AM	- POS AM POS AM UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization) (
July 3, 2012	S-8 POS	- S-8 POS S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization)
July 3, 2012	S-8 POS	- POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 POST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction
July 3, 2012	S-8 POS	- S-8 POS S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization)
July 3, 2012	S-8 POS	- S-8 POS S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization)
July 3, 2012	S-8 POS	- S-8 POS S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 22-3264604 (State or Other Jurisdiction of Incorporation or Organization)
June 22, 2012	EX-99.1	ERT Announces Stockholder Approval of Merger Press Release Exhibit 99.1 ERT Announces Stockholder Approval of Merger PHILADELPHIA, June 22, 2012 – eResearchTechnology, Inc. (Nasdaq: ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations, announced today that at a special meeting of stockholders held this morning, its stockholders approved, among other t
June 22, 2012	8-K	Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 22, 2012 eResearchTechnology, Inc.
June 12, 2012	8-K	Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15( D ) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): June 12, 2012 eResearchTechnology, Inc.
May 21, 2012	DEFM14A	- DEFINITIVE PROXY MATERIALS - ERESEARCHTECHNOLOGY, INC Definitive Proxy Materials - eResearchTechnology, Inc Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.
May 10, 2012	SC 13G/A	ERT / Eresearchtechnology Inc / FMR LLC Passive Investment SCHEDULE 13G Amendment No. 4 ERESEARCHTECHNOLOGY INC Common Stock Cusip #29481V108 Cusip #29481V108 Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 7,500 Item 6: 0 Item 7: 7,500 Item 8: 0 Item 9: 7,500 Item 11: 0.015% Item 12: HC Cusip #29481V108 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 7,500 Item 8: 0 Item 9: 7,500 It
May 9, 2012	PREM14A	- ERESEARCHTECHNOLOGY, INC. PRELIMINARY PROXY STATEMENT eResearchTechnology, Inc. Preliminary Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement. ¨ Confidential, for use of the Co
May 7, 2012	10-Q	Quarterly Report - FORM 10-Q Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.
May 7, 2012	EX-10.13	eResearchTechnology, Inc. 2012 Bonus Plan EX-10.13 2 d338851dex1013.htm EX-10.13 Exhibit 10.13 eResearchTechnology, Inc. 2012 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (“ERT” or the “Company”) 2012 Bonus Plan (the “2012 Plan”) approved by the Compensation Committee at its meeting on February 24, 2012, which was effective January 1, 2012. The purpose of the 2012 Plan is to promote the interests of the Company
May 7, 2012	8-K	- FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 7, 2012 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commi
May 7, 2012	EX-99.1	4 eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) Three Months Ended March 31, 2011 2012 Net revenues: Services $ 23,977 $ 26,555 Site support 17,722 23,950 Total net revenues Press Release Exhibit 99.1 ERT Reports First Quarter 2012 Operating Results • Revenues of $50.5 million • GAAP diluted net income per share of $0.08 / Non-GAAP diluted net income per share of $0.10 • Bookings of $76.3 million PHILADELPHIA, May 7, 2012 /PRNewswire-FirstCall/ — eResearchTechnology, Inc. (ERT), (Nasdaq: ERT—News), a global technology-driven provider of health outcomes research servic
May 7, 2012	EX-10.21	Preamble—Omitted § 1 Rented property EX-10.21 3 d338851dex1021.htm EX-10.21 Exhibit 10.21 Pursuant to Rule 12b-12(d)(3), set forth below is an English language summary of the Lease Agreement, dated February 2, 2012, between eResearchTechnology GmbH and KHF Grundbesitz GmbH & Co KG, the original of which is in German, including a summary of the material provisions thereof and a description of the provisions omitted from the summary. P
May 4, 2012	8-K	Entry into a Material Definitive Agreement - FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 1, 2012 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commi
April 30, 2012	EX-10.48	MANAGEMENT EMPLOYMENT AGREEMENT Management Employment Agreement Effective November 10, 2009 Exhibit 10.48 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as “Agreement”) is hereby entered into between John Sory (hereinafter known as “Employee”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”) and having its principal offices at 1818 Market Str
April 30, 2012	EX-10.49	Amendment to Management Employment Agreement Amendment to Management Employment Agreement Effective December 2010 Exhibit 10.49 Amendment to Management Employment Agreement This Agreement to Management Employment Agreement (the “Amendment”) is hereby entered into between John Sory (hereinafter known as the “Employee”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”): 1. TERM; TERMIN
April 30, 2012	10-K/A	Annual Report - FORM 10-K AMENDMENT NO. 1 Form 10-K Amendment No. 1 Table of Contents United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2011 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro
April 30, 2012	EX-10.47	Between ERICH JAEGER GmbH, 97204 Höchberg, Leibnizstraße 7, - hereinafter referred to as “the Firm” - Mr. Hans-Joachim Schülke, born 10.05.1961, 97320 Mainstockheim, Am Haselberg 16 - hereinafter referred to as “the Employee” - Employment Agreement Effective May 26, 1998 Exhibit 10.47 [English translation of agreement originally executed in German] Employment Agreement for Managerial Employee Between ERICH JAEGER GmbH, 97204 Höchberg, Leibnizstraße 7, - hereinafter referred to as “the Firm” - and Mr. Hans-Joachim Schülke, born 10.05.1961, 97320 Mainstockheim, Am Haselberg 16 - hereinafter referred to as “the Employee” -
April 30, 2012	EX-10.50	Exhbit 10.50 Letter Agreement Dated May 17, 2010 Exhbit 10.50 May 17, 2010 Achim, As you know the shares in Research Services Germany 234 GmbH will be transferred to a German affiliate of eResearch Technology, Inc., presumably at the end of this month. We are pleased to inform you that we as the new shareholder will safeguard that your salary to be received from Research Services Germany 234 GmbH will be 200,0
April 11, 2012	SC 13D/A	ERT / Eresearchtechnology Inc / BLUM CAPITAL PARTNERS LP - SCHEDULE 13D AMENDMENT NO. 10 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 10) Under the Securities Exchange Act of 1934 ERESEARCH TECHNOLOGY, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29481V108 - (CUSIP Number) Gwen G. Reinke Blum Capital Partners, L.P. 909 Montgomery Street, Suite 400 San Francisco, CA 94133 (415) 434-1111 - (Name, Address and
April 10, 2012	EX-10.1	CONSULTING AGREEMENT EX-10.1 3 d333775dex101.htm CONSULTING AGREEMENT DATED APRIL 10, 2012 Exhibit 10.1 EXECUTION COPY CONSULTING AGREEMENT This CONSULTING AGREEMENT (“Agreement) is made by and between Joel Morganroth, M.D., P.C., a Pennsylvania professional corporation (“Consultant”), and eResearchTechnology, Inc., a Delaware corporation (“Company”), as of April 9, 2012. WHEREAS, in connection with the consummation o
April 10, 2012	EX-99.1	ERT Announces Acquisition by Genstar Capital Press Release issued by eResearch technology, Inc. on April 10, 2012 Exhibit 99.1 ERT Announces Acquisition by Genstar Capital PHILADELPHIA, April 10, 2012 – eResearchTechnology, Inc. (ERT), (Nasdaq: ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a defi
April 10, 2012	EX-2.1	Execution Copy AGREEMENT AND PLAN OF MERGER by and among EXPLORER HOLDINGS, INC., EXPLORER ACQUISITION CORP. ERESEARCHTECHNOLOGY, INC. dated as of April 9, 2012 TABLE OF CONTENTS Page ARTICLE 1 THE MERGER 1 Section 1.01. The Closing 1 Section 1.02. T Agreement and Plan of Merger by and among Explorer Holdings, Inc dated 4/9/2012 Exhibit 2.
April 10, 2012	EX-99.1	ERT Announces Acquisition by Genstar Capital Press Release issued by eResearch technology, Inc. on April 10, 2012 Exhibit 99.1 ERT Announces Acquisition by Genstar Capital PHILADELPHIA, April 10, 2012 – eResearchTechnology, Inc. (ERT), (Nasdaq: ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a defi
April 10, 2012	EX-2.1	Execution Copy AGREEMENT AND PLAN OF MERGER by and among EXPLORER HOLDINGS, INC., EXPLORER ACQUISITION CORP. ERESEARCHTECHNOLOGY, INC. dated as of April 9, 2012 TABLE OF CONTENTS Page ARTICLE 1 THE MERGER 1 Section 1.01. The Closing 1 Section 1.02. T Agreement and Plan of Merger by and among Explorer Holdings, Inc dated 4/9/2012 Exhibit 2.
April 10, 2012	EX-10.1	CONSULTING AGREEMENT Consulting Agreement dated April 10, 2012 Exhibit 10.1 EXECUTION COPY CONSULTING AGREEMENT This CONSULTING AGREEMENT (“Agreement) is made by and between Joel Morganroth, M.D., P.C., a Pennsylvania professional corporation (“Consultant”), and eResearchTechnology, Inc., a Delaware corporation (“Company”), as of April 9, 2012. WHEREAS, in connection with the consummation of the transactions described
April 10, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): April 9, 2012 eResearchTechnology, Inc.
April 10, 2012	DEFA14A	- FORM 8-K DEFA14A 1 d333775d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): April 9, 2012 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction of Incorporation) 0-
April 10, 2012	EX-99.2	All ERT Staff Employee FAQ regarding the Merger Exhibit 99.2 To: All ERT Staff From: Jeffrey Litwin – President & CEO Date: April 10, 2012 Subject: ERT Announces Acquisition by Genstar To the entire ERT Team: Today we have announced a definitive agreement for the acquisition of ERT by Genstar Capital, a private equity firm based in California. Many of you will already have seen the public press release which wa
April 10, 2012	EX-99.2	All ERT Staff Employee FAQ regarding the Merger Exhibit 99.2 To: All ERT Staff From: Jeffrey Litwin – President & CEO Date: April 10, 2012 Subject: ERT Announces Acquisition by Genstar To the entire ERT Team: Today we have announced a definitive agreement for the acquisition of ERT by Genstar Capital, a private equity firm based in California. Many of you will already have seen the public press release which wa
March 2, 2012	EX-12.1	eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges Statement of Computation of Ratio of Earnings to Fixed Charges Exhibit 12.1 eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges The following table sets forth our ratio of earnings to fixed charges for the period indicated: Year Ended December 31, 2007 2008 2009 2010 2011 (dollars in thousands) Income before income taxes $ 24,457 $ 40,125 $ 17,478 $ 14,422 $ 18
March 2, 2012	10-K	Annual Report - FORM 10-K FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 2, 2012	EX-10.14	eResearchTechnology, Inc. 2011 Bonus Plan Bonus Plan Exhibit 10.14 eResearchTechnology, Inc. 2011 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (“ERT” or the “Company”) 2011 Bonus Plan (the “2011 Plan”) approved by the Compensation Committee and ratified by the Board of Directors at their respective meetings on December 7, 2010, to be effective for fiscal 2011. The purpose of the 2011 Plan is to promote the inte
March 1, 2012	8-K	- FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 24, 2012 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation)
February 27, 2012	8-K	- FORM 8-K FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 27, 2012 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation)
February 27, 2012	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) September 30, September 30, September 30, September 30, Three Months Ended December 31, Year Ended December 31, 2010 2011 2010 2 EX-99.1 Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2011 Operating Results • Record revenues of $52.3 million for the fourth quarter and $184.9 million for the full year 2011 • GAAP diluted net income per share of $0.09 for the fourth quarter / Non-GAAP diluted net income per share of $0.14 for the fourth quarter • Record bookings of $82.5 million for the fourth quarter / $303.5 million
February 14, 2012	SC 13G/A	ERT / Eresearchtechnology Inc / FMR LLC Passive Investment SCHEDULE 13G Amendment No. 3 ERESEARCHTECHNOLOGY INC Common Stock Cusip #29481V108 Cusip #29481V108 Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 7,500 Item 6: 0 Item 7: 5,607,874 Item 8: 0 Item 9: 5,607,874 Item 11: 11.389% Item 12: HC Cusip #29481V108 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 5,607,874 Item 8: 0 Ite
February 13, 2012	SC 13G/A	ERT / Eresearchtechnology Inc / COLUMBIA WANGER ASSET MANAGEMENT LLC - SCHEDULE 13G AMENDMENT NO. 6 Passive Investment Schedule 13G Amendment No. 6 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursua
February 13, 2012	EX-99.1	EXHIBIT 99.1 - JOINT FILING AGREEMENT Joint Filing Agreement Exhibit 99.1 EXHIBIT 99.1 - JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is respo
February 10, 2012	SC 13G/A	ERT / Eresearchtechnology Inc / BlackRock Inc. Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) ERESEARCH TECHNOLOGY INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 29481V108 - (CUSIP Number) December 30, 2011 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched
February 9, 2012	SC 13G	ERT / Eresearchtechnology Inc / VANGUARD GROUP INC Passive Investment eresearchtechnologyinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:0 )* Name of issuer: eResearchTechnology Inc Title of Class of Securities: Common Stock CUSIP Number: 29481V108 Date of Event Which Requires Filing of this Statement: December 31, 2011 Check the approp
February 6, 2012	8-K	Entry into a Material Definitive Agreement - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2012 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (
January 30, 2012	SC 13G	ERT / Eresearchtechnology Inc / TOCQUEVILLE ASSET MANAGEMENT L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* eResearch Technology, Inc. (Name of Issuer) Common Stocks (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu
January 11, 2012	LETTER	LETTER January 9, 2012 Via Email Dr. Jeffrey Litwin, M.D. President and Chief Executive Officer eResearchTechnology, Inc. 1818 Market Street Philadelphia, PA 19103 Re: eResearchTechnology, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed March 3, 2011 File No. 000-29100 Dear Dr. Litwin: We have completed our review of your filing. We remind you that our comments or changes to disclosure in re
January 3, 2012	SC 13D/A	ERT / Eresearchtechnology Inc / BLUM CAPITAL PARTNERS LP - SCHEDULE 13D AMENDMENT NO. 9 Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 9) Under the Securities Exchange Act of 1934 ERESEARCH TECHNOLOGY, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29481V108 - (CUSIP Number) Gwen G. Reinke Blum Capital Partners, L.P. 909 Montgomery Street, Suite 400 San Francisco, CA 94133 (415) 434-1111 - (Name, Address and
December 9, 2011	CORRESP	- Correspondence December 9, 2011 VIA EDGAR Securities and Exchange Commission 100 F Street, N.
November 30, 2011	LETTER	LETTER November 30, 2011 Via E-mail Dr. Joel Morganroth, M.D. President and Chief Executive Officer eResearchTechnology, Inc. 1818 Market Street Philadelphia, PA 19103 Re: eResearchTechnology, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed March 3, 2011 Responses dated August 22, 2011 and October 18, 2011 File No. 000-29100 Dear Dr. Morganroth: We have reviewed your filing and responses and
November 7, 2011	EX-10.17	Exhibit 10.17 Exhibit 10.17 EXECUTION COPY Guaranty Guaranty, dated as of May 27, 2010 (this ?Guaranty?), by ERT TECH CORPORATION, a Delaware corporation (?ERT Tech?), ERT INVESTMENT CORPORATION, a Delaware corporation (?ERT Investment?), COVANCE CARDIAC SAFETY SERVICES INC., a Pennsylvania corporation (?Covance?), each of the other entities that becomes a party hereto pursuant to Section 24 ( Additional Guaran
November 7, 2011	EX-2.1	Exhibit 2.1 Deed No. 134/2010 EXHIBIT 2.1 Recorded at Frankfurt am Main on this 29th day of April 2010, before me, the undersigned attorney-at-law Dr. Frank Schreiber as officially appointed representative of the Notary Dr. Klaus Sommerlad practicing in Frankfurt am Main appeared today: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfur
November 7, 2011	EX-2.2	Exhibit 2.2 Exhibit 2.2 Deed-No.161/2010 Notarial Deed recorded in Frankfurt am Main, Germany this 28th day of May 2010, Today before me, the undersigned Notary Dr. Klaus Sommerlad, with offices in Frankfurt am Main, Germany, there appeared: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfurt am Main, identified by presenting his valid
November 7, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2011 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num
November 7, 2011	EX-10.16	Exhibit 10.16 Exhibit 10.16 REVOLVER NOTE U.S. $40,000,000 May 27, 2010 Philadelphia, Pennsylvania FOR VALUE RECEIVED, ERESEARCHTECHNOLOGY, INC., a Delaware corporation (the ?Borrower?), hereby unconditionally promises to pay to the order of CITIZENS BANK OF PENNSYLVANIA (the ?Lender?) at its office located at 3025 Chemical Road, Suite 300, Plymouth Meeting, PA 19462, on the Termination Date (as defined in the
November 7, 2011	EX-10.15	Exhibit 10.15 Exhibit 10.15 EXECUTION COPY $40,000,000 CREDIT AGREEMENT between ERESEARCHTECHNOLOGY, INC., as the Borrower, and CITIZENS BANK OF PENNSYLVANIA, as the Lender Dated as of May 27, 2010 TABLE OF CONTENTS Page SECTION 1. DEFINITIONS 1 1.1. Defined Terms 1 1.2. Other Definitional Provisions 21 SECTION 2. LOANS AND TERMS OF COMMITMENTS 22 2.1. The Loans 22 2.2. Notes 23 2.3. Procedure for Revolver Loan
October 27, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissio
October 27, 2011	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2010 2011 2010 2011 Net revenues: Services $ 25,929 Exhibit 99.1 ERT Reports Third Quarter 2011 Operating Results ? Record revenues of $48.1 million ? Diluted net income per share ? GAAP of $0.09 / Non-GAAP of $0.11 ? Record bookings of $78.4 million ? Record backlog of $343.8 million PHILADELPHIA, Oct. 27, 2011 /PRNewswire/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERT) a global technology-driven provider of services and customizable medical dev
October 18, 2011	CORRESP	- Correspondence October 18, 2011 VIA EDGAR Securities and Exchange Commission 100 F Street, N.
September 8, 2011	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) (CUSIP Number) August 31, 2011 ( SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) August 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fi
September 8, 2011	EX-99.1	EXHIBIT 99.1 ? JOINT FILING AGREEMENT Exhibit 99.1 EXHIBIT 99.1 ? JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the complete
August 22, 2011	CORRESP	- Correspondence August 22, 2011 Securities and Exchange Commission 100 F Street, N.
August 11, 2011	LETTER	LETTER August 11, 2011 Via E-mail Dr. Joel Morganroth, M.D. President and Chief Executive Officer eResearchTechnology, Inc. 1818 Market Street Philadelphia, PA 19103 Re: eResearchTechnology, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed March 3, 2011 File No. 000-29100 Dear Dr. Morganroth: We have reviewed your filing and have the following comments. In some of our comments, we may ask you
August 8, 2011	S-8	As filed with the Securities and Exchange Commission on August 8, 2011 As filed with the Securities and Exchange Commission on August 8, 2011 Registration No.
August 5, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2011 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number:
August 5, 2011	EX-10.31	Exhibit 10.31 Exhibit 10.31 eResearchTechnology, Inc. Amended and Restated 2003 Equity Incentive Plan 1. Purpose The purpose of the Amended and Restated 2003 Equity Incentive Plan (referred to herein as the ?Plan?) of eResearchTechnology, Inc. (the ?Company?) is to provide a means by which certain employees and directors of, and others providing services to or having a relationship with, the Company and its sub
August 5, 2011	EX-10.44	Exhibit 10.44 Exhibit 10.44 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Jeffrey S. Litwin (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 1818 Market Street, Philadelphia PA 19103. 1. DUTIES AND RESPONSIBI
August 1, 2011	EX-3.1	Amended and Restated Bylaws eResearchTechnology, Inc. (as amended through July 27, 2011) Exhibit 3.1 Amended and Restated Bylaws of eResearchTechnology, Inc. (as amended through July 27, 2011) Table of Contents Page No. ARTICLE I CORPORATE OFFICES 1 Section 1.1 Registered Office 1 Section 1.2 Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 2.1 Place of Meetings 1 Section 2.2 Annual Meeting 1 Section 2.3 Special Meetings 1 Section 2.4 Advance Notice Procedures for Busines
August 1, 2011	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) Three Months Ended June 30, Six Months Ended June 30, 2010 2011 2010 2011 Net revenues: Services $ 18,697 $ 22,416 $ 33,532 $ 46 Exhibit 99.1 ERT Reports Second Quarter 2011 Operating Results ? Revenues of $42.8 million ? GAAP diluted net income per share of $0.04 / Non-GAAP diluted net income per share of $0.06 ? Bookings of $70.9 million ? Backlog of $333.2 million PHILADELPHIA, August 1, 2011 /PRNewswire-First Call/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERT ? News) a global technology-driven provider of services an
August 1, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission F
May 6, 2011	EX-10.49	Exhibit 10.49 Exhibit 10.49 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Thomas P. Devine (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Manageme
May 6, 2011	EX-10.48	Exhibit 10.48 Exhibit 10.48 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Thomas Devine (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITI
May 6, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2011 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number:
May 2, 2011	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) Three Months Ended March 31, 2010 2011 Net revenues: Services $ 14,835 $ 23,977 Site support 7,033 17,722 Total net Exhibit 99.1 ERT Reports First Quarter 2011 Operating Results ? Revenues of $41.7 million ? GAAP diluted net income per share of $0.06 / Non-GAAP diluted net income per share of $0.09 ? Bookings of $71.8 million PHILADELPHIA, May 2, 2011 /PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERT - News) a global technology-driven provider of services and customizable medical devices to
May 2, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission
May 2, 2011	EX-99.2	Media Contacts: Keith Schneck Robert East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5566 443-213-0502 ERT Announces Appointment of New President and CEO Exhibit 99.2 News Release Media Contacts: Keith Schneck Robert East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5566 443-213-0502 ERT Announces Appointment of New President and CEO PHILADELPHIA, May 2, 2011 /PRNewswire-First Call/ eResearchTechnology, Inc. (ERT), (Nasdaq: ERT ? News) a global technology-driven provider of services and customizable medical devices to bio-pharmaceutica
April 22, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission
April 22, 2011	EX-99.1	FIRM and AFFlLIATE OFFICES NEW YORK LONDON SINGAPORE LOS ANGELES CHICAGO HOUSTON HANOI PHILADELPHIA SAN DIEGO SAN FRANCISCO BALTIMORE BOSTON WASHINGTON, DC LAS VEGAS ATLANTA MIAMI PITTSBURGH NEWARK BOCA RATON WILMINGTON CHERRY HILL PRINCETON LAKE TAH Exhibit 99.1 FIRM and AFFlLIATE OFFICES NEW YORK LONDON SINGAPORE LOS ANGELES CHICAGO HOUSTON HANOI PHILADELPHIA SAN DIEGO SAN FRANCISCO BALTIMORE BOSTON WASHINGTON, DC LAS VEGAS ATLANTA MIAMI PITTSBURGH NEWARK BOCA RATON WILMINGTON CHERRY HILL PRINCETON LAKE TAHOE HO CHI MINH CITY SHELDON M. BONOVITZ DIRECT DIAL: 215.979.1972 PERSONAL FAX: 215.689.3546 E-MAIL: [email protected] www.duane
March 9, 2011	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14
March 3, 2011	EX-12.1	EXHIBIT 12.1 exv12w1 Exhibit 12.1 eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges The following table sets forth our ratio of earnings to fixed charges for the period indicated: Year Ended December 31, 2006 2007 2008 2009 2010 (dollars in thousands) Income before income taxes $ 13,215 $ 24,457 $ 40,125 $ 17,478 $ 14,422 Fixed charges: Interest expense $ 10 $ 106 $ 28 $
March 3, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2010 o TRANSITION REPORT PURSUANT TO SECTI Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2010 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTech
March 3, 2011	EX-21.1	EXHIBIT 21.1 Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization ERT Services, Inc. Delaware eRT Investment Corporation Delaware eRT Tech Corporation Delaware Covance Cardiac Safety Services Inc. Pennsylvania eResearchTechnology Limited United Kingdom eResearchTechnology UK 1 Limited United Kingdom eResearchTechnology UK 2 Limited United Kingdom eResearchTechnology GmbH Germany Biosigna G
March 3, 2011	EX-10.59	RETIREMENT AGREEMENT EX-10.59 2 w81789exv10w59.htm EX-10.59 EXHIBIT 10.59 RETIREMENT AGREEMENT This Retirement Agreement dated December 21, 2010 is made by and between eResearchTechnology, Inc., a Delaware corporation (“ERT”) and Michael J. McKelvey, an individual residing in Arlington, Virginia (“Executive”). Background ERT and Executive are parties to a Management Employment Agreement dated June 23, 2006, as amended
March 1, 2011	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) Three Months Ended December 31, Year Ended December 31, 2009 2010 2009 2010 Net revenues: Services $ 16,363 $ 26,257 Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2010 Operating Results ? Revenues of $44.9 million for the fourth quarter and $141.0 million for 2010 ? GAAP diluted net income per share of $0.08 for the fourth quarter / Non-GAAP diluted net income per share of $0.12 for the fourth quarter ? Bookings of $58.9 million for the fourth quarter ? 2011 guidance for revenue of $178 to $188 million /
March 1, 2011	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2011 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissi
February 14, 2011	SC 13G/A	DOC ONE SCHEDULE 13G Amendment No. 2 ERESEARCHTECHNOLOGY INC Common Stock Cusip #29481V108 Cusip #29481V108 Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 8,300 Item 6: 0 Item 7: 5,750,974 Item 8: 0 Item 9: 5,750,974 Item 11: 11.723% Item 12: HC Cusip #29481V108 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 5,750,974 Item 8: 0 Ite
February 10, 2011	EX-99.1	EXHIBIT 99.1 ? JOINT FILING AGREEMENT Exhibit 99.1 EXHIBIT 99.1 ? JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the complete
February 10, 2011	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) (CUSIP Number) December 31, 2010 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ERESEARCH TECHNOLOGY INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is
February 4, 2011	SC 13G/A	SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) ERESEARCH TECHNOLOGY INC - - (Name of Issuer) Common Stock - - (Title of Class of Securities) 29481V108 - - (CUSIP Number) December 31, 2010 - - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th
January 28, 2011	SC 13G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* eResearch Technology, Inc. (Name of Issuer) Common Stocks (Title of Class of Securities) (CUSIP Numbe UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* eResearch Technology, Inc. (Name of Issuer) Common Stocks (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi
January 4, 2011	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: December 31, 2010 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable i
December 21, 2010	EX-99.1	ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO Exhibit 99.1 Media Contacts: Fiona Robinson The Scott Partnership Tel: +44 1477 539539 [email protected] News Release John Blakeley ERT +1 215 972 0420 [email protected] ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO PHILADELPHIA, PA, 21 December 2010/PRNewswire-FirstCall/ ? ERT (Nasdaq: ERES - News), a global provider of technology and services to the pharmaceutical, biotechnol
December 21, 2010	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commissi
December 10, 2010	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commissio
November 30, 2010	424B3	eResearchTechnology, Inc. Debt Securities Common Stock Preferred Stock Depositary Shares Warrants Units Table of Contents As filed pursuant to Rule 424(b)(3) Registration Statement No. 333-170526 PROSPECTUS eResearchTechnology, Inc. $150,000,000 Debt Securities Common Stock Preferred Stock Depositary Shares Warrants Units We may offer from time to time to sell debt securities, common stock, preferred stock, depositary shares, warrants and units that include any of these securities. The debt securiti
November 10, 2010	EX-12.1	eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges exv12w1 Exhibit 12.1 eResearchTechnology, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges The following table sets forth our ratio of earnings to fixed charges for the period indicated: Nine Months Ended Year Ended December 31, Sept. 30, 2005 2006 2007 2008 2009 2010 (dollars in thousands) Income before income taxes: $ 24,372 $ 13,215 $ 24,457 $ 40,125 $ 17,478 $ 8,939 Fixed ch
November 10, 2010	S-3	As filed with the Securities and Exchange Commission on November 10, 2010 S-3 1 w80421sv3.htm FORM S-3 Table of Contents As filed with the Securities and Exchange Commission on November 10, 2010 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ERESEARCHTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Delaware 22-3264604 (State or other jur
November 10, 2010	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commissi
November 10, 2010	EX-99.1	ERT FILES SHELF REGISTRATION STATEMENT Exhibit 99.1 Contact: Keith Schneck Robert East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5566 410-321-9652 ERT FILES SHELF REGISTRATION STATEMENT PHILADELPHIA November 10, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, today announ
November 10, 2010	EX-4.1	ERESEARCHTECHNOLOGY, INC. Dated as of EXHIBIT 4.1 ERESEARCHTECHNOLOGY, INC. Company INDENTURE Dated as of Trustee CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310(a)(1) 7.10 (a)(2) 7.10 (a)(3) N.A. (a)(4) N.A. (a)(5) 7.10 (b) 7.10 (c) N.A. 311(a) 7.11 (b) 7.11 (c) N.A. 312(a) 2.05 (b) 12.03 (c) 12.03 313(a) 7.06 (b) 7.06 (c) 7.06; 12.02 (d) 7.06 314(a) 4.03; 12.02; 12.05 (c)(1) 12.04 (c)(2) 12.04 (c)(3) N.A. (e
November 9, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2010 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num
November 4, 2010	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissio
November 4, 2010	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2009 2010 2009 2010 Net revenues: Services $ 15,969 Exhibit 99.1 ERT Reports Third Quarter 2010 Results ? Revenues of $45.1 million for the third quarter ? up 99% from prior year ? GAAP diluted net income per share of $0.06 for the third quarter / Non-GAAP diluted net income per share of $0.11 for the third quarter ? Bookings of $59.1 million for the third quarter PHILADELPHIA, November 4, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT
September 16, 2010	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commiss
September 16, 2010	EX-99.1	ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer Exhibit 99.1 ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer PHILADELPHIA, September 10, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, today announced that Michael McKelvey will be retiring from his positions as Pr
August 9, 2010	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2009 2010 2009 2010 Net revenues: Services $ 16,215 $ 18,697 $ Exhibit 99.1 ERT Reports Second Quarter 2010 Results ? Revenues of $29.1 million for second quarter ? GAAP diluted net income per share of $0.02 for second quarter / Non-GAAP diluted net income per share of $0.08 for second quarter ? Bookings of $51.0 million ? Backlog reaches $299.4 million ? 2010 guidance for GAAP diluted net income per share of $0.16 to $0.21 / Non-GAAP diluted net income per s
August 9, 2010	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Commission
August 9, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2010 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number:
August 5, 2010	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 201 Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2010 (May 27, 2010) eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or oth
August 5, 2010	EX-99.2	RESEARCH SERVICES (A DIVISION OF CAREFUSION CORPORATION) CONDENSED COMBINED STATEMENTS OF OPERATIONS (unaudited) Three Three Months Ended Months Ended (in thousands) March 31, 2010 March 31, 2009 Product Revenue $ 6,630 $ 2,623 Service Revenue 9,769 Exhibit 99.2 RESEARCH SERVICES (A DIVISION OF CAREFUSION CORPORATION) CONDENSED COMBINED STATEMENTS OF OPERATIONS (unaudited) Three Three Months Ended Months Ended (in thousands) March 31, 2010 March 31, 2009 Product Revenue $ 6,630 $ 2,623 Service Revenue 9,769 4,246 Total Revenue 16,399 6,869 Cost of Products and Services Sold 8,095 4,272 Gross Margin 8,304 2,597 Selling, General and Administrat
August 5, 2010	EX-99.3	eResearchTechnology, Inc and Subsidiaries Unaudited Pro Forma Condensed Combined Financial Information Exhibit 99.3 eResearchTechnology, Inc and Subsidiaries Unaudited Pro Forma Condensed Combined Financial Information The accompanying unaudited pro forma condensed combined financial statements present the historical financial information of eResearchTechnology, Inc. (?ERT? or the ?Company?) as adjusted for the purchase of Research Services Germany 234 GmbH (?RS?), which was formed as a result of a
August 5, 2010	EX-99.1	Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft /s/ Bösser /s/ Muth Bösser Wirtschaftsprüfer Muth Wirtschaftsprüfer Exhibit 99.1 CareFusion Germany 234 GmbH H?chberg Carve Out Financial Statements of Research Services Division of CareFusion Germany 234 GmbH for the years ended December 31, 2008 and 2009 Ernst & Young GmbH Wirtschaftspr?fungsgesellschaft Report of Independent Auditors The Management Board of CareFusion Germany 234 We have audited the accompanying combined balance sheets of Research Services (com
June 3, 2010	EX-10.3	W i t n e s s e t h: Exhibit 10.3 EXECUTION COPY Guaranty Guaranty, dated as of May 27, 2010 (this ?Guaranty?), by ERT TECH CORPORATION, a Delaware corporation (?ERT Tech?), ERT INVESTMENT CORPORATION, a Delaware corporation (?ERT Investment?), COVANCE CARDIAC SAFETY SERVICES INC., a Pennsylvania corporation (?Covance?), each of the other entities that becomes a party hereto pursuant to Section 24 ( Additional Guarant
June 3, 2010	EX-10.1	$40,000,000 CREDIT AGREEMENT ERESEARCHTECHNOLOGY, INC., as the Borrower, CITIZENS BANK OF PENNSYLVANIA, as the Lender Dated as of May 27, 2010 EX-10.1 2 c02037exv10w1.htm EXHIBIT 10.1 Exhibit 10.1 EXECUTION COPY $40,000,000 CREDIT AGREEMENT between ERESEARCHTECHNOLOGY, INC., as the Borrower, and CITIZENS BANK OF PENNSYLVANIA, as the Lender Dated as of May 27, 2010 TABLE OF CONTENTS Page SECTION 1. DEFINITIONS 1 1.1. Defined Terms 1 1.2. Other Definitional Provisions 21 SECTION 2. LOANS AND TERMS OF COMMITMENTS 22 2.1. The Loans 22 2.2. N
June 3, 2010	EX-10.2	REVOLVER NOTE U.S. $40,000,000 May 27, 2010 Philadelphia, Pennsylvania Exhibit 10.2 REVOLVER NOTE U.S. $40,000,000 May 27, 2010 Philadelphia, Pennsylvania FOR VALUE RECEIVED, ERESEARCHTECHNOLOGY, INC., a Delaware corporation (the ?Borrower?), hereby unconditionally promises to pay to the order of CITIZENS BANK OF PENNSYLVANIA (the ?Lender?) at its office located at 3025 Chemical Road, Suite 300, Plymouth Meeting, PA 19462, on the Termination Date (as defined in the C
June 3, 2010	EX-10.4	DATED MAY 27, 2010 (1) ERESEARCHTECHNOLOGY, INC as Chargor (2) CITIZENS BANK OF PENNSYLVANIA as Chargee CHARGE OVER SHARES AND SECURITIES 160 Queen Victoria Street London EC4V 4QQ, UK Tel: +44 (0) 20 7184 7000 Fax: +44 (0) 20 7184 7001 Exhibit 10.4 EXECUTION COPY DATED MAY 27, 2010 (1) ERESEARCHTECHNOLOGY, INC as Chargor (2) CITIZENS BANK OF PENNSYLVANIA as Chargee CHARGE OVER SHARES AND SECURITIES 160 Queen Victoria Street London EC4V 4QQ, UK Tel: +44 (0) 20 7184 7000 Fax: +44 (0) 20 7184 7001 1. DEFINITIONS, CONSTRUCTION AND THIRD PARTY RIGHTS 2 2. COVENANT TO PAY 5 3. FIXED SECURITY 5 4. FURTHER ASSURANCE 5 5. REPRESENTATIONS
June 3, 2010	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission Fi
June 3, 2010	EX-99.1	ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation Exhibit 99.1 ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation PHILADELPHIA, June 1, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES ? News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, announced the successful closing of the acquisition of the Research Services Di
June 3, 2010	EX-10.5	Notarial Deed in Frankfurt am Main, Germany this 28th day of May 2010, Today before me, the undersigned Notary Dr. Klaus Sommerlad, with offices in Frankfurt am Main, Germany, there appeared: Exhibit 10.5 Deed-No.161/2010 Notarial Deed recorded in Frankfurt am Main, Germany this 28th day of May 2010, Today before me, the undersigned Notary Dr. Klaus Sommerlad, with offices in Frankfurt am Main, Germany, there appeared: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfurt am Main, identified by presenting his valid
May 12, 2010	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: May 10, 2010 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquir
May 7, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2010 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number:
May 7, 2010	EX-10.9	Exhibit 10.9 Deed No. 134/2010 EXHIBIT 10.9 Recorded at Frankfurt am Main on this 29th day of April 2010, before me, the undersigned attorney-at-law Dr. Frank Schreiber as officially appointed representative of the Notary Dr. Klaus Sommerlad practicing in Frankfurt am Main appeared today: a) Dr. Christoph Papenheim, born 28 March 1967, with business address c/o DLA Piper UK LLP, Westhafenplatz 1, 60327 Frankfu
May 7, 2010	EX-10.42	Exhibit 10.42 Exhibit 10.42 eResearchTechnology, Inc AMENDED AND RESTATED MANAGEMENT EMPLOYMENT AGREEMENT This Amended and Restated Management Employment Agreement (the “Agreement”) is hereby entered into effective March 1, 2010 between Joel Morganroth (hereinafter known as “Employee”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”) and having its pri
May 7, 2010	EX-10.46	Exhibit 10.46 Exhibit 10.46 eResearchTechnology, Inc. CONSULTANT AGREEMENT This Consultant Agreement (the “Agreement”) is hereby entered into effective the 1st day of March, 2010 by and between Joel Morganroth, M.D., P.C. (hereinafter known as “Consultant”) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”), and having its principal offices at 1818 Marke
May 7, 2010	EX-10.56	Exhibit 10.56 EXHIBIT 10.56 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Keith D. Schneck (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Manageme
May 7, 2010	EX-10.50	Exhibit 10.50 Exhibit 10.50 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Jeffrey S. Litwin (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Managem
May 7, 2010	EX-10.51	Exhibit 10.51 Exhibit 10.51 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Amy Furlong (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Management Em
May 7, 2010	EX-10.13	Exhibit 10.13 Exhibit 10.13 eResearchTechnology, Inc. 2010 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (?ERT? or the ?Company?) 2010 Bonus Plan (the ?2010 Plan?) approved by the Compensation Committee and ratified by the Board of Directors at their respective meetings on February 23, 2010, to be effective for fiscal 2010. The purpose of the 2010 Plan is to promote the interests of t
May 7, 2010	EX-10.10	Exhibit 10.10 EXHIBIT 10.10 RECIPROCAL GUARANTY THIS RECIPROCAL GUARANTY (this ?Guaranty?), dated as of April 29, 2010, is executed by CareFusion Corporation, a Delaware corporation (the ?Seller Guarantor?), in favor of Blitz F10-acht-drei-f?nf GmbH & Co. KG, a limited partnership organized under the laws of the Federal Republic of Germany (?Purchaser?), and by eResearchTechnology, Inc., a Delaware corporation
May 7, 2010	EX-10.49	Exhibit 10.49 Exhibit 10.49 Amendment No. 1 to Management Employment Agreement This Amendment No. 1 to Management Employment Agreement (the ?Amendment?) is hereby entered into between Michael McKelvey (hereinafter known as the ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?). Background The Employee and the Company are parties to a Manageme
April 30, 2010	EX-99.2	ERT First Quarter 2010 Earnings Results Conference Call April 29, 2010 Exhibit 99.2 ERT First Quarter 2010 Earnings Results Conference Call April 29, 2010 Good afternoon. Thank you for joining us for ERT?s first quarter 2010 earnings results conference call. A press release announcing the first quarter results was released this afternoon and is available at ERT.com and most financial websites. We also issued a press release this afternoon announcing the signing of a
April 30, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2010 eResearchTechnolog Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Co
April 30, 2010	EX-99.1	ERT Agrees to Acquire the Research Services Division of CareFusion Exhibit 99.1 ERT Agrees to Acquire the Research Services Division of CareFusion ? Adds market leadership in the respiratory core lab market to ERT?s existing market leading position in the cardiac safety core lab market ? Expands our high quality service and technology offerings to our pharmaceutical customers worldwide ? Establishes a global platform for growth with broad presence in the US and E
April 29, 2010	EX-99.1	ERT Reports First Quarter 2010 Results Conference Call to Discuss Acquisition and First Quarter Results of Operations to be held on April 29, 2010 at 5:00 PM EDT Exhibit 99.1 ERT Reports First Quarter 2010 Results Conference Call to Discuss Acquisition and First Quarter Results of Operations to be held on April 29, 2010 at 5:00 PM EDT PHILADELPHIA, April 29, 2010/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES ? News), a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, an
April 29, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2010 eResearchTechnolog Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Co
March 19, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2010 eResearchTechnolog Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Co
March 9, 2010	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: March 5, 2010 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inqui
March 5, 2010	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14
March 3, 2010	EX-10.55	MANAGEMENT EMPLOYMENT AGREEMENT Exhibit 10.55 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between John Sory (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 1818 Market Street, Philadelphia PA 19103. 1. DUTIES AND RESPONSIBILITIES E
March 3, 2010	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2009 o TRANSITION REPORT PURSUANT TO SECTI Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2009 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTech
March 1, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2010 eResearchTechno Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation)
February 25, 2010	EX-99.1	ERT Reports Fourth Quarter and Full Year 2009 Results Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2009 Results PHILADELPHIA, February 25, 2010/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (ERT), (Nasdaq: ERES — News), a leading provider of centralized ECG, ePRO, and other services to the bio/pharmaceutical, medical device and related industries, announced today results for the fourth quarter and twelve-month period ended December 31, 2
February 25, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2010 eResearchTechno Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2010 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation)
February 16, 2010	SC 13G/A	DOC ONE SCHEDULE 13G Amendment No. 1 ERESEARCHTECHNOLOGY INC Common Stock Cusip #29481V108 Cusip #29481V108 Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 872,219 Item 6: 0 Item 7: 6,069,402 Item 8: 0 Item 9: 6,069,402 Item 11: 12.523% Item 12: HC Cusip #29481V108 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 6,069,402 Item 8: 0 I
February 9, 2010	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* eresearch technology Inc ___________________________________________________________ (Name of Issuer) COMMON STOCK ___ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* eresearch technology Inc (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is
January 29, 2010	SC 13G	SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) ERESEARCH TECHNOLOGY INC SHS - - (Name of Issuer) Common Stock - - (Title of Class of Securities) 29481V108 - - (CUSIP Number) December 31, 2009 - - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
January 27, 2010	SC 13G/A	SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No.5) eResearch Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29481V108 (CUSIP Number) Date of Event Which Requires Filing of this Statement: December 31, 2009 *The remainde
January 5, 2010	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: December 31, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable i
January 5, 2010	SC 13D/A	SCHEDULE 13D AMENDMENT NO. 8 SC 13D/A 1 eres13d8.txt SCHEDULE 13D AMENDMENT NO. 8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 8) Under the Securities Exchange Act of 1934 ERESEARCH TECHNOLOGY, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29481V108 - (CUSIP Number) Gregory D. Hitchan Blum Capital Partners, L.P. 909 Montgomery Street, Suite 400 San
December 10, 2009	SC 13G	DOC ONE SCHEDULE 13G Amendment No. 0 ERESEARCHTECHNOLOGY INC Common Stock Cusip #29481V108 Cusip #29481V108 Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 851,780 Item 6: 0 Item 7: 6,001,357 Item 8: 0 Item 9: 6,001,357 Item 11: 12.382% Item 12: HC Cusip #29481V108 Item 1: Reporting Person - Edward C. Johnson 3d Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 6,001,357 Item 8: 0 I
November 9, 2009	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: November 5, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of
November 6, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2009 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num
November 6, 2009	EX-10.31	Exhibit 10.31 Exhibit 10.31 eResearchTechnology, Inc. Amended and Restated 2003 Equity Incentive Plan 1. Purpose The purpose of the Amended and Restated 2003 Equity Incentive Plan (referred to herein as the ?Plan?) of eResearchTechnology, Inc. (the ?Company?) is to provide a means by which certain employees and directors of, and others providing services to or having a relationship with, the Company and its sub
November 4, 2009	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: November 2, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of
October 29, 2009	EX-99.1	ERT Reports Third Quarter 2009 Results Exhibit 99.1 ERT Reports Third Quarter 2009 Results PHILADELPHIA, October 29, 2009/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - News), a leading provider of centralized ECG, ePRO and other services to the biopharmaceutical, medical device and related industries, announced today results for the third quarter and nine-month period ended September 30, 2009. Unless otherwis
October 29, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2009 eResearchTechnol Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2009 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (
September 10, 2009	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* eresearch technology Inc ___________________________________________________________ (Name of Issuer) COMMON STOCK ___ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* eresearch technology Inc (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) August 31, 2009 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is fi
August 7, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2009 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to . Commission file number
August 7, 2009	EX-10.28	Exhibit 10.28 Exhibit 10.28 MODIFICATION NUMBER ONE TO PROMISSORY NOTE AND LOAN AGREEMENT eResearchtechnology, Inc. a/k/a eResearch Technology, Inc. 1818 Market Street, Suite 1000 Philadelphia, Pennsylvania 19103-3638 eRT Investment Corporation 1105 N. Market Street, Suite 1300 Wilmington, Delaware 19801 eRT Tech Corporation 1105 N. Market Street, Suite 1300 Wilmington, Delaware 19801 (Individually and collecti
July 30, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2009 eResearchTechnology Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2009 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdiction of Incorporation) (Com
July 30, 2009	EX-99.1	ERT Reports Second Quarter 2009 Results Exhibit 99.1 ERT Reports Second Quarter 2009 Results PHILADELPHIA, July 30, 2009/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (ERT), (Nasdaq: ERES - - News), a leading provider of centralized ECG, ePRO and other services to the biopharmaceutical, medical device and related industries, announced today results for the second quarter and six-month period ended June 30, 2009. Unless otherwise not
July 6, 2009	SC 13D	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* OMNICOMM SYSTEMS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 682 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* OMNICOMM SYSTEMS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 68212 U 10 4 (CUSIP Number) Keith D. Schneck ERESEARCHTECHNOLOGY, INC. 1818 Market Street Philadelphia, PA 19103 (215) 972-0420 (Name, Address and Teleph
July 6, 2009	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: July 1, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquir
July 6, 2009	EX-1	LOCK-UP AND REGISTRATION RIGHTS AGREEMENT Exhibit 1 Exhibit 1 LOCK-UP AND REGISTRATION RIGHTS AGREEMENT THIS LOCK-UP AND REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of June 23, 2009 (the “Effective Date”), by and between eRESEARCHTECHNOLOGY, INC.
June 23, 2009	EX-99.1	OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology — Acquisition Extends the Company’s Suite of Products and Increases Breadth of EDC Customers — Exhibit 99.1 OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology ? Acquisition Extends the Company?s Suite of Products and Increases Breadth of EDC Customers ? June 23, 2009 FORT LAUDERDALE, FL & PHILADELPHIA, PA. ? (PRNewswire) ? OmniComm Systems, Inc.? (OTC BB:OMCM ? News) (?OmniComm?), a leader in integrated electronic data capture (EDC) solutions for clinical trials,
June 23, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 23, 2009 (Date of earliest event reported) eResearchTechnology e8vk Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.
May 8, 2009	EX-10.57	Exhibit 10.57 Exhibit 10.57 eResearchTechnology, Inc. MANAGEMENT EMPLOYMENT AGREEMENT The following agreement is hereby entered into between Joel Morganroth (hereinafter known as Employee) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 1818 Market Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIES Emplo
May 8, 2009	EX-10.14	Exhibit 10.14 Exhibit 10.14 eResearchTechnology, Inc. 2009 Bonus Plan Set forth below is a summary of the eResearchTechnology, Inc. (?ERT? or the ?Company?) 2009 Bonus Plan (the ?2009 Plan?) recommended by the Compensation Committee and approved by the Board of Directors at meetings on February 24 and 26, 2009, to be effective for fiscal 2009. The purpose of the 2009 Plan is to promote the interests of the Comp
May 8, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 c84874e10vq.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2009 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional perio
May 8, 2009	EX-10.58	Exhibit 10.58 Exhibit 10.58 eResearchTechnology, Inc. CONSULTANT AGREEMENT The following agreement is hereby entered into between, Joel Morganroth, M.D., P.C. (hereinafter known as Consultant) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”), and having its principal offices at 1818 Market Street, Philadelphia, PA 19103 1. SCOPE OF PROJECT a) Consultan
May 8, 2009	EX-10.32	Exhibit 10.32 Exhibit 10.32 FIRST AMENDMENT TO THE eResearchTechnology, Inc. AMENDED AND RESTATED 2003 EQUITY INCENTIVE PLAN WHEREAS, eResearchTechnology, Inc. (the “Company”) has adopted the eResearch Technology, Inc. Amended and Restated 2003 Equity Incentive Plan (the “Plan”) for the benefit of certain of its employees and directors; and WHEREAS, the Company has reserved the right to amend the Plan at any ti
May 8, 2009	EX-10.45	Exhibit 10.45 Exhibit 10.45 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Amy Furlong (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIES
May 5, 2009	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: May 1, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry
April 30, 2009	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 30, 2009 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission
April 30, 2009	EX-99.1	ERT Reports First Quarter 2009 Results EX-99.1 2 w73847exv99w1.htm EXHIBIT 99.1 Exhibit 99.1 ERT Reports First Quarter 2009 Results PHILADELPHIA, April 30, 2009/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (ERT), (Nasdaq: ERES — News), a leading provider of centralized ECG, eClinical technology, ePRO and other services to the biopharmaceutical, medical device, and related industries, announced today results for the first quarter o
March 13, 2009	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin
March 2, 2009	8-K	Current Report 8-K 1 c81920e8vk.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2009 eResearchTechnology, Inc. (Exact name of registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other Jurisdicti
March 2, 2009	10-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2008 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTechnology, Inc. (
March 2, 2009	EX-10.53	MANAGEMENT EMPLOYMENT AGREEMENT Exhibit 10.53 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Keith D. Schneck hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILI
February 26, 2009	EX-99.1	ERT Reports Fourth Quarter and Full Year 2008 Results Filed by Bowne Pure Compliance Exhibit 99.1 ERT Reports Fourth Quarter and Full Year 2008 Results Q4 2008 Net Revenues — $30.1 million vs. $28.9 million in Q4 2007 — a 4.0% increase Q4 2008 Diluted Net Income per Share — $0.11 vs. $0.10 in Q4 2007 — a 10.0% increase Q4 2008 New Bookings of $45.1 million vs. $39.2 million in Q4 2007 — a 15.1% increase 2008 Net Revenues — $133.1 million vs. $98.7 mi
February 26, 2009	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2009 eResearchTechno Filed by Bowne Pure Compliance UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 10, 2009	SC 13G/A	SC 13G/A OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response 11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 10, 2009	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9)* eResearchTechnology, Inc. (Name of Issuer) Common Stock, $.01 par value per share (Title of Class of Sec OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response.
February 6, 2009	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* eresearchtechnology Inc ___________________________________________________________ (Name of Issuer) COMMON STOCK ____ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* eresearchtechnology Inc (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29481V108 (CUSIP Number) December 31, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is f
January 23, 2009	SC 13G/A	SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No.4) eResearch Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29481V108 (CUSIP Number) Date of Event Which Requires Filing of this Statement: December 31, 2008 *The remainde
January 9, 2009	LETTER	LETTER
January 5, 2009	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Date of Earliest Transaction Required to be Reported: January 2, 2009 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inq
January 5, 2009	SC 13D/A	SCHEDULE 13D AMENDMENT NO. 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 7) Under the Securities Exchange Act of 1934 ERESEARCH TECHNOLOGY, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29481V108 - (CUSIP Number) Gregory D. Hitchan Blum Capital Partners, L.P. 909 Montgomery Street, Suite 400 San Francisco, CA 94133 (415) 434-1111 - (Name, Address
December 24, 2008	CORRESP	Sincerely, /s/ Keith D. Schneck Executive Vice President, Chief Financial Officer and Secretary December 24, 2008 via Edgar Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7010 Re: eResearchTechnology, Inc. Form 10-K for fiscal year ended December 31, 2007 Filed March 7, 2008 File No. 000-29100 Ladies and Gentlemen: Set forth below is the comment contained in your December 10, 2008 letter with respect to the above-captioned filing, together with our response to t
December 10, 2008	LETTER	LETTER
November 24, 2008	CORRESP	Re: eResearchTechnology, Inc. Form 10-K for fiscal year ended December 31, 2007 Filed March 7, 2008 File No. 000-29100 corresp November 24, 2008 via Edgar Securities and Exchange Commission 100 F Street, N.
November 19, 2008	CORRESP	November 19, 2008 corresp November 19, 2008 via Edgar Securities and Exchange Commission 100 F Street, N.
November 7, 2008	EX-10.20	Exhibit 10.20 Exhibit 10.20 1818 MARKET STREET OFFICE LEASE BETWEEN NNN 1818 Market Street, LLC, NNN 1818 Market Street 1, LLC, NNN 1818 Market Street 2, LLC, NNN 1818 Market Street 3, LLC, NNN 1818 Market Street 4, LLC, NNN 1818 Market Street 5, LLC, NNN 1818 Market Street 6, LLC, NNN 1818 Market Street 7, LLC, NNN 1818 Market Street 8, LLC, NNN 1818 Market Street 9, LLC, NNN 1818 Market Street 10, LLC, NNN 18
November 7, 2008	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2008 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file num
November 7, 2008	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: November 7, 2008 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of
November 7, 2008	SC 13D/A	SCHEDULE 13D AMENDMENT NO. 6 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 6) Under the Securities Exchange Act of 1934 ERESEARCH TECHNOLOGY, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29481V108 - (CUSIP Number) Gregory D. Hitchan Blum Capital Partners, L.P. 909 Montgomery Street, Suite 400 San Francisco, CA 94133 (415) 434-1111 - (Name, Address
November 5, 2008	LETTER	LETTER
October 30, 2008	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 30, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction (Commission (I.R.S. Employer
October 30, 2008	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2007 2008 2007 2008 Net revenues: Licenses $ 651 $ eResearchTechnology Reports Third Quarter 2008 Results Q3 2008 Net Revenues — $33.
September 9, 2008	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: September 5, 2008 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best o
August 25, 2008	SC 13D/A	SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 5) Under the Securities Exchange Act of 1934 ERESEARCH TECHNOLOGY, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) 29481V108 - (CUSIP Number) Gregory D. Hitchan Blum Capital Partners, L.P. 909 Montgomery Street, Suite 400 San Francisco, CA 94133 (415) 434-1111 - (Name, Address
August 22, 2008	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: March 10, 2008 Issuer & Symbol: Electronics for Imaging, Inc. (EFII) Address of each Reporting Person for this Form 3: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best o
August 14, 2008	EX-99	EX-99 EXHIBIT 99 Joint Filer Information Designated Filer: BLUM CAPITAL PARTNERS, L.P. Statement for Month/Day/Year: August 12, 2008 Issuer & Symbol: eResearch Technology, Inc. (ERES) Address of each Reporting Person for this Form 4: 909 Montgomery Street, Suite 400, San Francisco, CA 94133 Relationship to Issuer of each Reporting Person: 10% Owner Signatures After reasonable inquiry and to the best of
August 7, 2008	EX-10.29	Exhibit 10.29 EXHIBIT 10.29 LOAN AGREEMENT Wachovia Bank, National Association Philadelphia, Pennsylvania 19109 (Hereinafter referred to as the ?Bank?) eResearch Technology, Inc. 30 South 17th Street 8th Floor Philadelphia, Pennsylvania 19103 eRT Investment Corporation 3411 Silverside Road 103 Springer Building Wilmington, Delaware 19810 eRT Tech Corporation 3411 Silverside Road 103 Springer Building Wilmington
August 7, 2008	SC 13G/A	SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No.3) eResearch Technology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29481V108 (CUSIP Number) Date of Event Which Requires Filing of this Statement: July 31, 2008 *The remainder of
August 7, 2008	EX-10.51	Exhibit 10.51 EXHIBIT 10.51 AMENDED AND RESTATED MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into on June 17, 2008 between Steven M. Eisenstein (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?), a Delaware corporation having its principal offices at 30 S.
August 7, 2008	EX-10.30	Exhibit 10.30 EXHIBIT 10.30 PROMISSORY NOTE $3,000,000.00 June26, 2008 eResearch Technology, Inc. 30 South 17th Street 8th Floor Philadelphia, Pennsylvania 19103 eRT Investment Corporation 3411 Silverside Road 103 Springer Building Wilmington, Delaware 19810 eRT Tech Corporation 3411 Silverside Road 103 Springer Building Wilmington, Delaware 19810 (Individually and collectively, ?Borrower?) Wachovia Bank, Natio
August 7, 2008	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2008 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number 0
August 4, 2008	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 30, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission F
August 4, 2008	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2007 2008 2007 2008 Net revenues: Licenses $ 580 $ 870 $ 1,362 Exhibit 99.1 eResearchTechnology Reports Second Quarter 2008 Results Q2 2008 Net Revenues ? a record $35.5 million vs. $24.7 million in Q2 2007 ? an increase of 43.4% Q2 2008 Diluted Net Income per Share ? $0.13 vs. $0.08 in Q2 2007 ? an increase of 62.5% Q2 2008 Operating Income margin of 30.3% vs. 25.3% in Q2 2007 Q2 2008 New Bookings of $49.0 million vs. $34.5 million in Q2 2007 PHILADELPHIA, A
July 23, 2008	EX-99.1	Contact: Michael McKelvey Robert East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5916 410-321-9652 exv99w1 Exhibit 99.1 eResearchTechnology Names New Chief Financial Officer PHILADELPHIA, July 23/PRNewswire-FirstCall/ — eResearchTechnology, Inc. (eRT or the Company), (Nasdaq: ERES - News), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today the appointment of Mr. Keit
July 23, 2008	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 23, 2008 (Date of earliest event reported) eResearchTechnology e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 23, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commiss
July 18, 2008	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 14, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission F
June 18, 2008	8-K	Current Report 8-K 1 w61289e8vk.htm FORM 8-K ERESEARCHTECHNOLOGY, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: June 17, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (Sta
May 20, 2008	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 20, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commission Fi
May 20, 2008	EX-99.1	Contact: Richard Baron Robert East eResearchTechnology, Inc. Westwicke Partners, LLC 215-282-5566 410-321-9652 Exhibit 99.1 eResearchTechnology Announces Resignation of its CFO PHILADELPHIA, May 20/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today that Richard Baron has informed the company that he
May 8, 2008	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) þ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2008 or o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transitional period from to Commission file number
May 8, 2008	EX-10.47	Management Employment Agreement EXHIBIT 10.47 MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between Robert Brown (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIE
May 8, 2008	EX-10.13	2008 Bonus Plan Exhibit 10.13 eResearchTechnology, Inc. 2008 Bonus Plan Set forth below is a summary of the 2008 Bonus Plan recommended by the Compensation Committee and approved by the Board of Directors on February 19, 2008, to be effective for fiscal 2008. The purpose of the plan is to promote the interests of the Company and its stockholders by providing employees with financial rewards upon achievement of sp
May 5, 2008	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 5, 2008 (Date of earliest event reported) eResearchTechnology, e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: May 5, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissio
May 5, 2008	EX-99.1	eResearchTechnology, Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) Three Months Ended March 31, 2007 2008 (unaudited) (unaudited) Net revenues: Licenses $ 782 $ 625 Services 13,968 25,273 Site su exv99w1 eResearchTechnology Reports First Quarter 2008 Results Q1 2008 Net Revenues — $33.
March 11, 2008	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) DEF 14A 1 w51050def14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, f
March 7, 2008	EX-10.42	Management Employment Agreement - Joel Morganroth Exhibit 10.42 eResearchTechnology, Inc. MANAGEMENT EMPLOYMENT AGREEMENT The following agreement is hereby entered into between Joel Morganroth (hereinafter known as Employee) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1. DUTIES AND RESPONSIBILITIES Employ
March 7, 2008	EX-21.1	Subsidiaries of the Registrant Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization eResearchTechnology Limited United Kingdom eRT Investment Corporation Delaware eRT Tech Corporation Delaware Covance Cardiac Safety Services Inc. Pennsylvania
March 7, 2008	EX-10.46	Consultant Agreement - Joel Morganroth Exhibit 10.46 eResearchTechnology, Inc. CONSULTANT AGREEMENT The following agreement is hereby entered into between, Joel Morganroth, M.D., P.C. (hereinafter known as Consultant) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the “Company”), and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103 1. SCOPE OF PROJECT a) Consultant
March 7, 2008	EX-10.45	Management Employment Agreement - George Tiger Exhibit 10.45 eResearchTechnology, Inc. MANAGEMENT EMPLOYMENT AGREEMENT The following agreement (hereinafter known as ?Agreement?) is hereby entered into between George Tiger (hereinafter known as ?Employee?) and eResearchTechnology, Inc. (together with its affiliated corporations hereinafter known as the ?Company?) and having its principal offices at 30 S. 17th Street, Philadelphia, PA 19103. 1.
March 7, 2008	10-K	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2007 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year ended December 31, 2007 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 0-29100 eResearchTechnology, Inc. (
February 27, 2008	EX-99.1	CORRECTION — eResearchTechnology, Inc, Exhibit 99.1 CORRECTION ? eResearchTechnology, Inc, PHILADELPHIA, February 27, 2008/PRNewswire-FirstCall/ ? In the news release, eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results, issued yesterday, February 26, by eResearchTechnology, Inc. over PR Newswire, we are advised by the company that in the ?Conference Call? section, the United States phone number to listen to the confe
February 27, 2008	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 26, 2008 (Date of earliest event reported) e8vkza UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 26, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of i
February 26, 2008	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 26, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Commissi
February 26, 2008	EX-99.1	eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results Q4 2007 Net Revenues — $28.9 million vs. $19.9 million in Q4 2006 — a 45% increase Q4 2007 Diluted Net Income per Share — $0.10 vs. $0.04 in Q4 2006 Q4 2007 New Bookings Increase t Exhibit 99.1 eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results Q4 2007 Net Revenues ? $28.9 million vs. $19.9 million in Q4 2006 ? a 45% increase Q4 2007 Diluted Net Income per Share ? $0.10 vs. $0.04 in Q4 2006 Q4 2007 New Bookings Increase to $39.2 million PHILADELPHIA, February 26, 2008/PRNewswire-FirstCall/ ? eResearchTechnology, Inc. (eRT), (Nasdaq: ERES - News), a leading
February 25, 2008	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 19, 2008 (Date of earliest event reported) eResearchTechno e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 19, 2008 (Date of earliest event reported) eResearchTechnology, Inc. (Exact name of Registrant as specified in its charter) Delaware 0-29100 22-3264604 (State or other jurisdiction of incorporation) (Com
February 11, 2008	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event February 11, 2008 reported e8vkza UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 to CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event February 11, 2008 reported): (November 28, 2007) eResearchTechnology, Inc. (Exact Name of Registrant Specified in Charter) Delaware 0-29100 22-3264604 (State or Other
February 11, 2008	EX-99.2	COVANCE CARDIAC SAFETY SERVICES, INC. BALANCE SHEETS AS OF SEPTEMBER 30, 2007 AND DECEMBER 31, 2006 September 30, December 31, 2007 2006 (Dollars in thousands) (Unaudited) Assets Current Assets: Cash and cash equivalents $ — $ — Accounts receivable, Exhibit 99.2 COVANCE CARDIAC SAFETY SERVICES, INC. BALANCE SHEETS AS OF SEPTEMBER 30, 2007 AND DECEMBER 31, 2006 September 30, December 31, 2007 2006 (Dollars in thousands) (Unaudited) Assets Current Assets: Cash and cash equivalents $ ? $ ? Accounts receivable, net 5,352 5,172 Deferred income taxes 212 212 Prepaid expenses and other current assets 372 452 Total Current Assets 5,936 5,836 Property
February 11, 2008	EX-99.3	eResearchTechnology , Inc. and Subsidiaries Unaudited Pro Forma Condensed Combined Financial Information EX-99.3 5 w48347exv99w3.htm THE UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET OF THE COMPANY AS OF SEPTEMBER 30, 2007 Exhibit 99.3 eResearchTechnology , Inc. and Subsidiaries Unaudited Pro Forma Condensed Combined Financial Information The accompanying unaudited pro forma condensed combined financial statements present the historical financial information of eResearchTechnology, Inc. (“ERT”
February 11, 2008	EX-99.1	Financial Statements For the Years Ended December 31, 2006 and 2005 and Nine Months Ended September 30, 2007 and 2006 Financial Statements For the Years Ended December 31, 2006 and 2005 and Nine Months Ended September 30, 2007 and 2006 Contents Exhibit 99.

ERT / Eresearchtechnology Inc - SEC-Einreichungen, Jahresbericht, Proxy Statement

Basisstatistiken

SEC Filings

SEC Filings (Chronological Order)

How Much do you Like Fintel?

Write a Review and get 25% Off Your Next Purchase

How can we Improve?